Supplier
Ou Medicine INC.
Ou Medicine INC. was paid $16K by Medicaid between Aug 2023 and Nov 2024, across 3 billing codes. Its largest line is J7503, Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg — 93% of everything it billed.
33Billing provider infoOU MEDICINE INC.
OKLAHOMA CITY, OK 73104
OKLAHOMA CITY, OK 73104
33aNPI1851602866assigned 06/24/2010
33bProvider typeCommunity/Retail Pharmacy
28Total paid$16K
24GClaims643
24DCodes billed3
24AFirst – last monthAug 2023 – Nov 2024
Compared with peers
Next to other Community/Retail Pharmacy providers in Oklahoma
Rank by total paid#2 of 5
Median peer was paid$4K
This provider vs. median4.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 57 | $112.48 | |
| 2024incomplete | 586 | $16K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | 93% | 102 | 78 | $14K |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 4.0% | 230 | 216 | $619.50 |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 3.3% | 311 | 201 | $518.11 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPETTY, LAURA (DIRECTOR OF RETAIL PHARMACY)